An interventional study of FertyBiotic Pregnancy and Control in Pregnancy Related, sponsored by Fertypharm. Active, not recruiting at 2 sites in Spain. Open to female participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-04.
Sponsored by Fertypharm · Not applicable, Interventional, and Supportive care
The aim of this study is determine the effect of a food supplement with probiotics on metabolic profile and weight gain in pregnant women.
After being informed about the study, all patients meeting the inclusion/exclusion criteria and giving written informed consent all patients will be treated with the food supplement that contain vitamins, minerals and probiotics. All volunteers will receive one capsule per day of the food supplement throughout the study. The duration of the supplementation will be from their inclusion in the study (≤ 14 weeks of gestation) until the 30th-32nd week of pregnancy, the time of the end-of-study visit.
Fertypharm is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants received FertyBiotic Pregnancy one capsule a day
Dietary Supplement: FertyBiotic Pregnancy · Other: Control
DHA, folic acid, Iodine, iron, Lactobacillus rhamnosus, Lactobacillus reuterii, magnesium, zinc, vitamin D3, Vitamin C, Vitamin E, Group B vitamins and Biotin
400 mcg of folic acid
Glucose homeostasis
Glucose homeostasis status will be evaluated by measuring fasting glucose
Time frame: 30-32 weeks gestation
Insulin levels
Insulin levels status will be evaluated by measuring fasting insulin
Time frame: 30-32 weeks gestation
Insulin resistance
Insulin resistance will be evaluated by measuring HOMA IR and QUICKI index (fasting glucose and fasting insulin combination)
Time frame: 30-32 weeks gestation
Weight gain
Weight will be evaluated weighting the subjects
Time frame: 30-32 weeks gestation
Lipid concentration
Lipid concentration will be evaluated by measuring fasting total colesterol, LDL, HDL and triglyceride
Time frame: 30-32 weeks gestation
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.